Table 1.
TCGA datasets considered and used for miRNA and cancer stage association analyses after filtration
| Dataset | Abbreviation | Original samples | Final samples | miRNAs |
|---|---|---|---|---|
| Bladder urothelial carcinoma | BLCA | 412 | 407 | 477 |
| Breast invasive carcinoma | BRCA | 1097 | 386 | 503 |
| Colon adenocarcinoma | COAD | 458 | 221 | 444 |
| Esophageal carcinoma | ESCA | 185 | 162 | 459 |
| Head and neck squamous cell carcinoma | HNSC | 528 | 420 | 498 |
| Kidney renal clear cell carcinoma | KIRC | 537 | 256 | 420 |
| Kidney renal papillary cell carcinoma | KIRP | 291 | 261 | 438 |
| Liver hepatocellular carcinoma | LIHCC | 377 | 348 | 540 |
| Lung adenocarcinoma | LUAD | 522 | 452 | 477 |
| Lung squamous cell carcinoma | LUSC | 504 | 339 | 494 |
| Skin cutaneous melanoma | SKCM | 470 | 389 | 483 |
| Stomach adenocarcinoma | STAD | 443 | 381 | 459 |
| Thyroid carcinoma | THCA | 503 | 500 | 474 |
| Rectum adenocarcinoma | READ | 171 | 66 | 465 |
| Uveal melanoma | UVM | 80 | 79 | 486 |